Chelerythrine Chloride is an Affinity-Labeling Inactivator of CYP3A4 by Modification of Cysteine239
- 8 February 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (4) , 2802-2811
Abstract
Chelerythrine chloride (CHE) is a quaternary benzo[c]phenanthridine alkaloid with an iminium group that was found to cause time- and concentration-dependent inhibition of CYP3A4. The loss of CYP3A4 activity was independent of NADPH. CYP3A4 competitive inhibitor ketoconazole and nucleophile N-acetylcysteine (NAC) slowed the inactivation. No recovery of CYP3A4 activity was observed after dialysis. Dihydrochelerythrine hardly inhibited CYP3A4, suggesting that the iminium group was primarily responsible for the inactivation. UV spectral analysis revealed that the maximal absorbance of CHE produced a significant red-shift after being mixed with NAC, suggesting that 1,2-addition possibly took place between the sulfhydryl group of NAC and iminium group of CHE. Molecular dynamics simulation and site-direct mutagenesis studies demonstrated that modification of Cys239 by the iminium group of CHE attributed to the inactivation. In conclusion, CHE is an affinity-labeling inactivator of CYP3A4. The observed enzyme inactivation resulted from the modification of Cys239 of CYP3A4 by the iminium group of CHE.Keywords
Funding Information
- Natural Science Foundation of Guizhou Province ([2021]5619, ZK[2022] key 037)
- Natural Science Foundation of Heilongjiang Province (LH2022H101)
- National Natural Science Foundation of China (82304607)
This publication has 27 references indexed in Scilit:
- Influence of Solvent Polarity and DNA-Binding on Spectral Properties of Quaternary Benzo[c]phenanthridine AlkaloidsPLOS ONE, 2015
- Functional Gene Variants of CYP3A4Clinical Pharmacology & Therapeutics, 2014
- Drug interactions with phytotherapeutics in oncologyExpert Opinion on Drug Metabolism & Toxicology, 2014
- Bioactivation of Sitaxentan in Liver Microsomes, Hepatocytes, and Expressed Human P450s with Characterization of the Glutathione Conjugate by Liquid Chromatography Tandem Mass SpectrometryChemical Research in Toxicology, 2013
- Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in FranceEuropean Journal of Clinical Pharmacology, 2012
- Multiwfn: A multifunctional wavefunction analyzerJournal of Computational Chemistry, 2011
- Time-Dependent Inactivation of P450 3A4 by Raloxifene: Identification of Cys239 as the Site of Apoprotein Alkylation1Chemical Research in Toxicology, 2007
- HPLC quantification of seven quaternary benzo[c]phenanthridine alkaloids in six species of the family PapaveraceaeJournal of Pharmaceutical and Biomedical Analysis, 2007
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- A Molecular Orbital Theory of Reactivity in Aromatic HydrocarbonsThe Journal of Chemical Physics, 1952